Health Care Reform and Investment in New Drug Development.

Examines the implications of health care reform for pharmaceutical innovation. Describes the dominant features of the drug development process and the forces shaping the current U.S. prescription drug market. Discusses the elements of recent proposals for health care reform that are likely to have t...

Full description

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 1995-1996.
Series:	U.S. Congressional Research.
Subjects:	Health facilities. Medicine > Research. Pharmaceutical industry. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Examines the implications of health care reform for pharmaceutical innovation. Describes the dominant features of the drug development process and the forces shaping the current U.S. prescription drug market. Discusses the elements of recent proposals for health care reform that are likely to have the biggest impact on the incentives to invest in the development of new drugs, and how those elements, individually and together, could affect those incentives.
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource.
Physical Description:	1 online resource.